HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Today, Medivir AB (OMX: MVIR), a research-based specialty pharmaceutical company focused on infectious diseases, is publishing its Interim Report for the period 1 January – 31 December and its operational report for the fourth quarter of 2011.
